Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination

OBJECTIVE: We aimed to examine the regulation of lipocalin-2 (LCN2) in multiple sclerosis (MS) and its potential functional relevance with regard to myelination and neurodegeneration. METHODS: We determined LCN2 levels in 3 different studies: (1) in CSF and plasma from a case-control study comparing...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Nimer, Faiez, Elliott, Christina, Bergman, Joakim, Khademi, Mohsen, Dring, Ann M., Aeinehband, Shahin, Bergenheim, Tommy, Romme Christensen, Jeppe, Sellebjerg, Finn, Svenningsson, Anders, Linington, Christopher, Olsson, Tomas, Piehl, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708925/
https://www.ncbi.nlm.nih.gov/pubmed/26770997
http://dx.doi.org/10.1212/NXI.0000000000000191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708925/
https://www.ncbi.nlm.nih.gov/pubmed/26770997
http://dx.doi.org/10.1212/NXI.0000000000000191

Ejemplares similares